Pancreatic Cancer Research

ResearcherUniversity of Southern DenmarkNo recent work listed

Jon Kroll Bjerregaard

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1088-7242; OpenAlex author ID A5053042879. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 3 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 2 papers

Papers 13

  1. Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer. Co-author DOI 10.1016/j.ejca.2020.10.038↗
  2. Response to the letter entitled: Re: Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival i… Co-author DOI 10.1016/j.ejca.2021.09.009↗
  3. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer. Co-author DOI 10.1111/ecc.13219↗
  4. Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer. Co-author DOI 10.1158/1055-9965.epi-19-0672↗
  5. S-1 (Teysuno) and gemcitabine in Caucasian patients with unresectable pancreatic adenocarcinoma. First author DOI 10.1007/s00280-018-3528-5↗
  6. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Co-author DOI 10.1007/s10585-017-9849-7↗
  7. Incidence of pancreatic cancer in Denmark: 70 years of registration, 1943-2012. First author DOI 10.1080/0284186x.2017.1351036↗
  8. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. Co-author DOI 10.1001/jama.2013.284664↗
  9. Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients. Co-author DOI 10.1016/j.ejca.2012.07.017↗
  10. In reply to Parlak and Topkan. Re: Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer trea… Co-author DOI 10.1016/j.ijrobp.2012.06.001↗
  11. Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer. Co-author DOI 10.1371/journal.pone.0067059↗
  12. Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy. Co-author DOI 10.1016/j.ijrobp.2011.09.008↗
  13. Feasibility of FDG-PET/CT imaging during concurrent chemo-radiotherapy in patients with locally advanced pancreatic cancer. Co-author DOI 10.3109/0284186x.2011.577095↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Per Pfeiffer · 11 shared papers, 2011–2021 · strength 0.78
  2. Julia Sidenius Johansen · 6 shared papers, 2013–2021 · strength 0.47
  3. Astrid Zedlitz Johansen · 4 shared papers, 2020–2021 · strength 0.40
  4. Louise S. Rasmussen · 4 shared papers, 2020–2021 · strength 0.40
  5. Inna Markovna Chen · 4 shared papers, 2020–2021 · strength 0.40
  6. Carsten Palnæs Hansen · 4 shared papers, 2017–2021 · strength 0.38
  7. Michael Bau Mortensen · 5 shared papers, 2011–2017 · strength 0.25
  8. Sture Falkmer · 2 shared papers, 2021 · strength 0.21
  9. Karin Bagni · 1 shared paper, 2020 · strength 0.09
  10. Mette Nissen · 1 shared paper, 2020 · strength 0.09
  11. Mathilde Weisz Ejlsmark · 1 shared paper, 2018 · strength 0.09
  12. Stine Brændegaard Winther · 1 shared paper, 2018 · strength 0.09
  13. Martin Graversen · 1 shared paper, 2017 · strength 0.09
  14. Sönke Detlefsen · 1 shared paper, 2017 · strength 0.09
  15. Tanja C Weble · 1 shared paper, 2017 · strength 0.08
  16. Christoffer Johansen · 1 shared paper, 2017 · strength 0.08
  17. Dan Calatayud · 2 shared papers, 2013–2014 · strength 0.07
  18. Nicolai A. Schultz · 2 shared papers, 2013–2014 · strength 0.07
  19. Klaus Kaae Andersen · 1 shared paper, 2014 · strength 0.04
  20. Nathalia A. Giese · 1 shared paper, 2013 · strength 0.03
  21. Jens Werner · 1 shared paper, 2013 · strength 0.03
  22. Poul Flemming Høilund‐Carlsen · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.